Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2000
11/16/2000WO2000068260A1 Methods for protein purification using aqueous two-phase extraction
11/16/2000WO2000068259A2 Vaccine
11/16/2000WO2000068258A2 Compounds exhibiting an antibiotic activity
11/16/2000WO2000068256A1 Cephaibols, novel antiparasitics from acremonium tubakii, method for the production and the utilization thereof
11/16/2000WO2000068253A1 Dna promoter sequence for gene expression
11/16/2000WO2000068251A1 Biological production of stable glutamine, poly-glutamine derivatives in transgenic organisms and their use for therapeutic purposes
11/16/2000WO2000068250A1 7tm receptor rat apj
11/16/2000WO2000068249A2 Novel g-protein modulator (gpm) proteins and nucleic acid molecules and uses therefor
11/16/2000WO2000068248A2 Self assembling proteins
11/16/2000WO2000068247A2 Serine proteases
11/16/2000WO2000068244A1 7tm receptor mouse apj
11/16/2000WO2000068243A1 Methods using mechanisms of action of aroa
11/16/2000WO2000068242A1 Collagen-binding proteins from enterococcal bacteria
11/16/2000WO2000068140A1 Signal transduction response regulator family of staphylococcus
11/16/2000WO2000067793A1 Death domain containing receptor 4
11/16/2000WO2000067786A1 PRODUCTION OF NOVEL NEWCASTLE DISEASE VIRUS STRAINS FROM cDNAS AND IMPROVED LIVE ATTENUATED NEWCASTLE DISEASE VACCINES
11/16/2000WO2000067783A1 509hk
11/16/2000WO2000067775A1 Fibroblast growth factor 15
11/16/2000WO2000067771A1 Antiangiogenic endostatin peptides, endostatin variants and methods of use
11/16/2000WO2000067761A1 Compositions and methods for identifying antigens which elicit an immune response
11/16/2000WO2000067700A2 Recombinant vaccine against botulinum neurotoxin
11/16/2000WO2000067575A1 0623hk
11/16/2000WO2000053633A3 Antibody and chemokine constructs that are directed to ccr5, and their use for treating autoimmune diseases
11/16/2000WO2000047223A3 Viral vaccine
11/16/2000WO2000046376A3 Particles for gene therapy
11/16/2000WO2000044406A3 Dna vaccines against hantavirus infections
11/16/2000WO2000043508A3 Cancer-associated proteins
11/16/2000WO2000042204A3 Trans-acting factors in yeast
11/16/2000WO2000042191A3 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
11/16/2000WO2000042179A3 Complex-forming proteins
11/16/2000WO2000039149A3 Secreted proteins and uses thereof
11/16/2000WO2000037639A3 Lymphocytic membrane proteins
11/16/2000WO2000037482A3 Peptides and peptide analogues designed from hfe protein and their uses in the treatment of iron overload diseases
11/16/2000WO2000036110A3 Plant disease resistance genes
11/16/2000WO2000034784A9 Protein scaffolds for antibody mimics and other binding proteins
11/16/2000WO2000034511A3 Aβ-PEPTIDE SCREENING ASSAY
11/16/2000WO2000034493A3 Regulatory sequences of the mouse villin gene - use in transgenesis
11/16/2000WO2000034468A3 Muc-1 antagonists and methods of treating immune disorders
11/16/2000WO2000034331A3 Analogues of glp-1
11/16/2000WO2000032796A3 Kinetoplastid protein expression system
11/16/2000WO2000029561A3 Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope
11/16/2000WO2000029012A3 Methods of alleviating cancer symptoms
11/16/2000WO2000028032A3 Human cell surface receptor proteins
11/16/2000WO2000026370A3 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
11/16/2000WO2000026247A3 Ikaros isoforms and mutants
11/16/2000WO2000026241A3 Novel compositions and methods of screening for t-cell and b-cell activation modulators
11/16/2000WO2000025578A3 Methods for cloning animals
11/16/2000WO2000023621A3 Visualization of rna in living cells
11/16/2000WO2000023466A3 Human rna binding proteins
11/16/2000WO2000023464A3 Zinc finger binding domains for gnn
11/16/2000WO2000022439A3 Method and substances for diagnosis and therapy of sepsis and sepsis-like systemic infections
11/16/2000WO2000022110A3 Targeted proteolysis by recruitment to ubiquitin protein ligases
11/16/2000WO2000020448A3 Nlk1 -interacting proteins
11/16/2000WO2000018916A3 Human genes and gene expression products
11/16/2000WO2000009549A3 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use
11/16/2000WO2000007631A9 Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response
11/16/2000WO2000006717A9 Improved transformation efficiency in phage display through modification of a coat protein
11/16/2000WO2000005375A9 Gbs toxin receptor
11/16/2000WO2000000158A3 Alkylamines and their precursors as specific modulators of human gamma-delta t cell function
11/16/2000WO1999066025A3 Mtbx protein and nucleic acid molecules and uses therefor
11/16/2000WO1999058981A3 Diagnostic tests for alzheimer's disease
11/16/2000WO1999051186A3 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
11/16/2000DE19920514A1 Methoden zur Auffindung von Proteasen, die spezifisch membrangebundene Substrate spalten Methods for the detection of proteases that cleave specific membrane-bound substrates
11/16/2000DE19919225A1 Tumorassoziiertes Antigen Tumor-associated antigen
11/16/2000DE19919149A1 Von Interferon alpha-2 abgeleitete Peptid-Homodimere und Peptid-Heterodimere Of interferon alpha-2 derived peptide homodimers and peptide heterodimers
11/16/2000DE19919148A1 Von Interleukin 12 abgeleitete Peptid-Homodimere und Peptid-Heterodimere Interleukin 12 derived peptide homodimers and peptide heterodimers
11/16/2000CA2721199A1 Isolating biological modulators from biodiverse gene fragment libraries
11/16/2000CA2503110A1 Collagen-binding proteins from enterococcal bacteria
11/16/2000CA2388092A1 Stereoselective antifibrillogenic peptides and peptidomimetics thereof
11/16/2000CA2374237A1 Compositions and methods for identifying antigens which elicit an immune response
11/16/2000CA2373759A1 Serine proteases
11/16/2000CA2373507A1 Prp-like gene
11/16/2000CA2373063A1 Death domain containing receptor 4
11/16/2000CA2372983A1 Recombinant penicillium funiculosum for homologous and heterologous protein production
11/16/2000CA2372902A1 Rad51-like orthologues and uses thereof
11/16/2000CA2372881A1 Novel nucleic acids and proteins with p53 activity and altered tetramerization domains
11/16/2000CA2372871A1 Novel nucleic acids and proteins with growth hormone activity
11/16/2000CA2372854A1 Identification of candida albicans essential fungal specific genes and use thereof in antifungal drug discovery
11/16/2000CA2372837A1 Cytokine receptor mouse zcytor10
11/16/2000CA2372823A1 Combinatorial metabolic libraries
11/16/2000CA2372821A1 Antimicrobial theta defensins and methods of using same
11/16/2000CA2372815A1 Extracellular matrix and adhesion-associated proteins
11/16/2000CA2372807A1 Constitutive chimeric receptors, and methods of use thereof
11/16/2000CA2372805A1 Autotaxin variants and uses to treat diseases of metabolism
11/16/2000CA2372738A1 Low-dose il-1.beta.-induced photoreceptor cell rescue without retinal dysplasia
11/16/2000CA2372699A1 Methods for treating tumors using antiangiogenic compounds
11/16/2000CA2372515A1 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use
11/16/2000CA2372513A1 Methods for protein purification using aqueous two-phase extraction
11/16/2000CA2372497A1 Vaccine composition comprising r28 protein of streptococcus pyogenes
11/16/2000CA2372213A1 Antibodies and peptides for detection of plasmodium vivax
11/16/2000CA2371902A1 Novel nucleic acids and proteins with interferon-beta activity
11/16/2000CA2371279A1 Recombinant vaccine against botulinum neurotoxin
11/16/2000CA2371193A1 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir)
11/16/2000CA2370512A1 Soybean homolog of disease resistance factor coi1
11/16/2000CA2370212A1 Methods of discovering proteases which specifically cleave membrane-bound substrates
11/16/2000CA2370027A1 Seed specific promoters
11/16/2000CA2370017A1 Plant defensins
11/16/2000CA2369605A1 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same
11/16/2000CA2333434A1 Maize rad50 orthologue and uses thereof
11/15/2000EP1052288A1 Complex for transferring an anionic substance of interest into a cell
1 ... 2093 2094 2095 2096 2097 2098 2099 2100 2101 2102 2103 2104 2105 2106 2107 2108 2109 2110 2111 2112 2113 ... 2916